MarginsXMarginsX
Home › Markets › Health Care › STXS

Stereotaxis Inc. (STXS)

STXS trades on NYSE in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.8027
-4.80% on the day
Market cap
$80.4M
Micro cap
Revenue · 2025
$32.4M
+20.3% on 2024
Net income · 2025
-$21.6M
-66.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1289340/000149315226009881/0001493152-26-009881-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSTXS on NYSE
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001289340
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$32.4M
Net income-$21.6M
Operating income-$22.1M
Net margin-66.8%
Operating margin-68.3%
Revenue growth+20.3%
Cash$13.4M
Total assets$52.3M
P/E (computed)Net income was not positive
P/S (computed)2.5×

Warning signs

Cash runway
8.2 months
$10.5M cash at June 30, 2026
Share count, 1 year
+10.5%
2025-07-31 to 2026-07-31 · +23.9% over 3 years
Going-concern doubt
No
10-Q filed August 12, 2026
Insider net buying, 12 months
$67K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-12
Cash and burn$10.5M cash; operating cash flow -$3.8M a quarter.Report 2026-06-30
Shares outstanding100,202,178 (2026-07-31); 90,653,769 a year earlier; 80,868,280 three years earlier.Cover page 2026-07-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months3 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-07-15
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Saint Louis, Missouri, United StatesPCAOB Form AP 2026-04-13
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $67K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$7.7M-$4.5M-$3.7M$10.5MNo debt tags$30.1M10-Q 2026-08-12
Q1 2026
2026-03-31
$6.3M-$5.9M-$3.4M$14.6MNo debt tags$31.2M10-Q 2026-05-13
Q4 2025
2025-12-31
$8.6M-$5.5M-$4.0M$13.4MNo debt tags$32.4M10-K 2026-03-12
Q3 2025
2025-09-30
$7.5M-$6.5M-$4.2M$10.5MNo debt tags$30.1M10-Q 2025-11-12
Q2 2025
2025-06-30
$8.8M-$3.8M-$3.7M$7.0MNo debt tags$31.8M10-Q 2026-08-12
Q1 2025
2025-03-31
$7.5M-$5.8M-$1.8M$10.6MNo debt tags$27.5M10-Q 2026-05-13
Q4 2024
2024-12-31
$6.3M-$7.5M$1.3M$12.2MNo debt tags$26.9M10-K 2026-03-12
Q3 2024
2024-09-30
$9.2M-$6.2M-$4.3M$10.7MNo debt tags$25.1M10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-08-13
Latest annual report10-K/A2026-04-03
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-10
Latest proxyDEFA14A2026-04-03

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-22.9%
1 month-20.8%
3 months-39.1%
Year to date-63.5%
1 year-62.5%
From 52-week high-69.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
VANIVivani Medical Inc. Common Stock (DE)$1.02+0.99%$92.0M
NRXSNeuraxis Inc.$4.80-11.44%$68.1M
HYPRHyperfine Inc.$0.6101-3.05%$64.8M
OMOutset Medical Inc.$3.39-9.12%$64.0M
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M
ECORelectroCore Inc.$4.84-7.81%$44.7M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier